Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Aclaris Therapeutics, Inc.

NASDAQ: ACRSHealthcare / Biotechnology / USA
6.41-0.1300-1.99%Vol 354 4021Y Perf -67.99%
Feb 21st, 2019 16:00
BID6.41 ASK6.42
Open6.51 Previous Close6.54
Pre-Market- After-Trading6.41
 - -%  - -%
Target Price
39.50 
Analyst Rating
Strong Buy 1.00
Potencial %
516.23 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/38 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/90 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/94 
Income Ranking
 —    -
Market Cap (mil)262 
Earnings Rating
Price Range Ratio 52wk %
2.79 
Earnings Date
11th Mar 2019

Today's Price Range

6.326.65

 

52wk Range

5.9522.41

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
4.23%
3 Months
-25.12%
6 Months
-58.70%
1 Year
-67.99%
3 Years
-61.75%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACRS6.41-0.1300-1.99
AAPL171.06-0.9700-0.56
GOOG1 096.97-16.8300-1.51
MSFT109.412.26002.11
XOM77.82-0.7100-0.90
WFC49.56-0.2500-0.50
JNJ135.42-0.9300-0.68
FB160.04-2.5200-1.55
GE10.03-0.0700-0.69
JPM105.47-0.2200-0.21
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
6.10
Current Ratio
6.50
Long Term Debt to Total Capital
-
Total Debt to Equity
0.00
Interest Coverage
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
44.80
EBIT Margin
-1 641.50
EBITDA Margin
-1 626.70
Pre-tax Profit Margin
-
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
2.01
PS Ratios
56.17
Price to Cash Flow
-
Price to Free Cash Flow
-3.90
Cash Flow Per Share
-2.97
Price to Tangible Book
2.44
Book Value per Share
3.57
Enterprise Value (in ths.)
159 832
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-33.62
ROE last 12 Months
-60.36
Return on Assets (5Y Avg)
-14.74
ROA last 12 Months
-53.86
Return on Capital (5Y Avg)
-
ROC last 12 Months
-59.79
Return on invested Capital Q
-20.36
Return on invested Capital Y
-34.69
Assets Turnover
0.00
Receivables Turnover
7.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
5 422
Revenue per Share
0.13
Revenue Growth 3 Years
-
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-1.25-1.0615.20
Q02 2018-0.95-1.01-6.32
Q01 2018-0.99-0.981.01
Q04 2017-0.90-0.8011.11
Q03 2017-0.86-0.6326.74
Q02 2017-0.68-0.5617.65
Q01 2017-0.54-0.4811.11
Q04 2016-0.59-0.4916.95
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.96-1.05Negative
12/2018 QR-1.27-7.63Negative
12/2018 FY-4.01-0.25Negative
12/2019 FY-3.66-3.39Negative
Next Report Date11th Mar 2019
Estimated EPS Next Report-0.96
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume354 402
Shares Outstanding (in ths.)40 936
Trades Count1 859
Dollar Volume1 967 628
Avg. Volume443 662
Avg. Weekly Volume450 711
Avg. Monthly Volume414 178
Avg. Quarterly Volume579 374

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

43%57%

Bearish Bullish

61%39%

Bearish Bullish

63%37%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
5 (100.00 %)
5 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News